Lv5
880 积分 2022-06-07 加入
Tumor-Infiltrating Natural Killer Cells
15天前
已完结
Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy
23天前
已完结
A perspective on small molecules targeting the Renin-Angiotensin-Aldosterone System and their utility in cardiovascular diseases: Exploring the structural insights for rational drug discovery and development
1个月前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
2个月前
已完结
Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells
2个月前
已完结
How can we improve the successful identification of patients suitable for CAR-T cell therapy?
2个月前
已完结
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
2个月前
已关闭
Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
2个月前
已完结
AML-389 Phase 1/2 Study of SEL24/MEN1703, a First-in-Class Dual PIM/FLT3 Kinase Inhibitor, in Patients With IDH1/2-Mutated Acute Myeloid Leukemia: The DIAMOND-01 Trial
2个月前
已完结
皖公网安备34019202002308
